Document Detail

CO(2)-assisted High Pressure Homogenization: A Solvent-Free Process for Polymeric Microspheres and Drug-Polymer Composites.
MedLine Citation:
PMID:  22750408     Owner:  NLM     Status:  Publisher    
The study explores the enabling role of near-critical CO(2) as a reversible plasticizer in the high pressure homogenization of polymer particles, aiming at their comminution as well as at the formation of drug-polymer composites. First, the effect of near-critical CO(2) on the homogenization of aqueous suspensions of poly lactic-co-glycolic acid (PLGA) was investigated. Applying a pressure drop of 900 bar and up to 150 passes across the homogenizer, it was found that particles processed in the presence of CO(2) were generally of microspherical morphology and at all times significantly smaller than those obtained in the absence of a plasticizer. The smallest particles, exhibiting a median x(50) of 1.3μm, were obtained by adding a small quantity of ethyl acetate, which exerts on PLGA an additional plasticizing effect during the homogenization step. Further, the study concerns the possibility of forming drug-polymer composites through simultaneous high pressure homogenization of the two relevant solids, and particularly the effect of near-critical CO(2) on this process. Therefore, PLGA was homogenized together with crystalline S-ketoprofen (S-KET), a non-steroidal anti-inflammatory drug, at a drug to polymer ratio of 1:10, a pressure drop of 900 bar and up to 150 passes across the homogenizer. When the process was carried out in the presence of CO(2), an impregnation efficiency of 91 % has been reached, corresponding to 8.3wt.% of S-KET in PLGA; moreover, composite particles were of microspherical morphology and significantly smaller than those obtained in the absence of CO(2). The formation of drug-polymer composites through simultaneous homogenization of the two materials is thus greatly enhanced by the presence of CO(2), which increases the efficiency for both homogenization and impregnation.
Johannes Kluge; Marco Mazzotti
Related Documents :
22886628 - Azone analogues: classification, design, and transdermal penetration principles.
22591598 - Personalized medicine: is it a pharmacogenetic mirage?
2143458 - Cardiovascular effects of isradipine (lomir) with special emphasis on haemodynamics and...
14824408 - Sustained hypertension following the administration of desoxycorticosterone acetate.
8000378 - Lymphocyte stimulation test with tetrazolium-based colorimetric assay for diagnosis of ...
6737268 - Hypolipidemic activity of 4-phenyl-5,5-dicarbethoxy-2-pyrrolidinone in rodents.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-6-28
Journal Detail:
Title:  International journal of pharmaceutics     Volume:  -     ISSN:  1873-3476     ISO Abbreviation:  -     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-7-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7804127     Medline TA:  Int J Pharm     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012. Published by Elsevier B.V.
ETH Zurich, Institute of Process Engineering Sonneggstrasse 3, 8092 Zurich, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Two-layered dissolving microneedles formulated with intermediate-acting insulin.
Next Document:  Zebrafish Mef2ca and Mef2cb are essential for both first and second heart field cardiomyocyte differ...